Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea

The pathophysiological mechanisms of growth impairment frequently associated with the obstructive sleep apnea syndrome (OSAS) in children are poorly defined. The main objective of this study was to evaluate whether nighttime upper airway obstruction attributable to adenotonsillar hypertrophy and sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 2002-04, Vol.109 (4), p.e55-e55
Hauptverfasser: Nieminen, Peter, Lopponen, Tuija, Tolonen, Uolevi, Lanning, Peter, Knip, Mikael, Lopponen, Heikki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e55
container_issue 4
container_start_page e55
container_title Pediatrics (Evanston)
container_volume 109
creator Nieminen, Peter
Lopponen, Tuija
Tolonen, Uolevi
Lanning, Peter
Knip, Mikael
Lopponen, Heikki
description The pathophysiological mechanisms of growth impairment frequently associated with the obstructive sleep apnea syndrome (OSAS) in children are poorly defined. The main objective of this study was to evaluate whether nighttime upper airway obstruction attributable to adenotonsillar hypertrophy and subsequent surgical treatment affect the circulating concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding protein 3 (IGFBP-3) along with other growth parameters in children. We initially studied 70 children (mean age: 5.8 years; range: 2.4-10.5 years) admitted to a university hospital because of clinical symptoms of OSAS. Their sleep was monitored with a 6-channel computerized polygraph. Data on anthropometry and circulating concentrations of IGF-I and IGFBP-3 were generated and compared with corresponding characteristics in control children (N = 35). Thirty children with an obstructive apnea-hypopnea index (OAHI) of 1 or more were categorized as children with OSAS (mean OAHI: 5.4 [95% confidence interval for mean (CI): 3.8-6.9]), whereas 40 children with an OAHI of 2 underwent adenotonsillectomy attributable to OSAS and were reassessed 6 months later together with 34 nonoperated children with OAHI
doi_str_mv 10.1542/peds.109.4.e55
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71577642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>126443601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-3ce780af27c449a83b0994bcf509aaa9764c4c19a617d72b021c5fc2fd1494793</originalsourceid><addsrcrecordid>eNpdkEtLxDAURoMoOj62LiW4cNeapMmkWY6DL1BcqLiSkKa3NmNfJq2D_96ODoy4ug_OPVw-hI4piang7LyDPMSUqJjHIMQWmox9GnEmxTaaEJLQiBMi9tB-CAtCCBeS7aI9ShWTkqUT9Hrt22VfYtPk-MK1toTaWVPhe-PfwQfcFnhNuAbPS1flHhr84sbFY9N617z9nD5kofeD7d0n4McKoMOzrgFziHYKUwU4WtcD9Hx1-TS_ie4erm_ns7vIJkL2UWJBpsQUTFrOlUmTjCjFM1sIoowxSk655ZYqM6UylywjjFpRWFbklCsuVXKAzn69nW8_Bgi9rl2wUFWmgXYIWlIhRwkbwdN_4KIdfDP-phlLEz5VP7b4F7K-DcFDoTvvauO_NCV6lbpepT4OSnM9pj4enKytQ1ZDvsHXMW-MpXsrl87DyuBM750Nf9qN8RtBPI5f</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228346979</pqid></control><display><type>article</type><title>Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Nieminen, Peter ; Lopponen, Tuija ; Tolonen, Uolevi ; Lanning, Peter ; Knip, Mikael ; Lopponen, Heikki</creator><creatorcontrib>Nieminen, Peter ; Lopponen, Tuija ; Tolonen, Uolevi ; Lanning, Peter ; Knip, Mikael ; Lopponen, Heikki</creatorcontrib><description>The pathophysiological mechanisms of growth impairment frequently associated with the obstructive sleep apnea syndrome (OSAS) in children are poorly defined. The main objective of this study was to evaluate whether nighttime upper airway obstruction attributable to adenotonsillar hypertrophy and subsequent surgical treatment affect the circulating concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding protein 3 (IGFBP-3) along with other growth parameters in children. We initially studied 70 children (mean age: 5.8 years; range: 2.4-10.5 years) admitted to a university hospital because of clinical symptoms of OSAS. Their sleep was monitored with a 6-channel computerized polygraph. Data on anthropometry and circulating concentrations of IGF-I and IGFBP-3 were generated and compared with corresponding characteristics in control children (N = 35). Thirty children with an obstructive apnea-hypopnea index (OAHI) of 1 or more were categorized as children with OSAS (mean OAHI: 5.4 [95% confidence interval for mean (CI): 3.8-6.9]), whereas 40 children with an OAHI of &lt;1 were considered as primary snorers (PS) (mean OAHI 0.13 [95% CI: 0.05-0.21]). Nineteen children with OAHI &gt;2 underwent adenotonsillectomy attributable to OSAS and were reassessed 6 months later together with 34 nonoperated children with OAHI &lt;2. There were no initial differences in relative height and weight for height between the 3 groups of children. No differences were observed in peripheral IGF-I concentrations, but both OSAS and PS children had reduced peripheral IGFBP-3 levels. The operated children with initial OSAS experienced a highly significant reduction in their OAHI from 7.1 (95% CI: 5.1-9.1) to 0.37 (95% CI: 0.2-0.95). Weight-for-height, body mass index, body fat mass, and fat-free mass increased during the follow-up in the operated children with OSAS, whereas only fat-free mass and relative height increased in the PS children. Both the IGF-I and the IGFBP-3 concentrations increased significantly in the operated children, whereas no significant changes were seen in the PS children. These observations indicate that growth hormone secretion is impaired in children with OSAS and PS. Respiratory improvement after adenotonsillectomy in children with OSAS results in weight gain and restored growth hormone secretion.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.109.4.e55</identifier><identifier>PMID: 11927728</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>United States: Am Acad Pediatrics</publisher><subject>Adenoidectomy ; Anthropometry ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Growth ; Humans ; Infant ; Insulin-Like Growth Factor Binding Protein 3 - metabolism ; Insulin-Like Growth Factor I - metabolism ; Male ; Pediatrics ; Sleep Apnea, Obstructive - complications ; Sleep Apnea, Obstructive - physiopathology ; Sleep Apnea, Obstructive - surgery ; Snoring - complications ; Snoring - physiopathology ; Tonsillectomy ; Weight Gain</subject><ispartof>Pediatrics (Evanston), 2002-04, Vol.109 (4), p.e55-e55</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts Apr 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-3ce780af27c449a83b0994bcf509aaa9764c4c19a617d72b021c5fc2fd1494793</citedby><cites>FETCH-LOGICAL-c357t-3ce780af27c449a83b0994bcf509aaa9764c4c19a617d72b021c5fc2fd1494793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11927728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nieminen, Peter</creatorcontrib><creatorcontrib>Lopponen, Tuija</creatorcontrib><creatorcontrib>Tolonen, Uolevi</creatorcontrib><creatorcontrib>Lanning, Peter</creatorcontrib><creatorcontrib>Knip, Mikael</creatorcontrib><creatorcontrib>Lopponen, Heikki</creatorcontrib><title>Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>The pathophysiological mechanisms of growth impairment frequently associated with the obstructive sleep apnea syndrome (OSAS) in children are poorly defined. The main objective of this study was to evaluate whether nighttime upper airway obstruction attributable to adenotonsillar hypertrophy and subsequent surgical treatment affect the circulating concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding protein 3 (IGFBP-3) along with other growth parameters in children. We initially studied 70 children (mean age: 5.8 years; range: 2.4-10.5 years) admitted to a university hospital because of clinical symptoms of OSAS. Their sleep was monitored with a 6-channel computerized polygraph. Data on anthropometry and circulating concentrations of IGF-I and IGFBP-3 were generated and compared with corresponding characteristics in control children (N = 35). Thirty children with an obstructive apnea-hypopnea index (OAHI) of 1 or more were categorized as children with OSAS (mean OAHI: 5.4 [95% confidence interval for mean (CI): 3.8-6.9]), whereas 40 children with an OAHI of &lt;1 were considered as primary snorers (PS) (mean OAHI 0.13 [95% CI: 0.05-0.21]). Nineteen children with OAHI &gt;2 underwent adenotonsillectomy attributable to OSAS and were reassessed 6 months later together with 34 nonoperated children with OAHI &lt;2. There were no initial differences in relative height and weight for height between the 3 groups of children. No differences were observed in peripheral IGF-I concentrations, but both OSAS and PS children had reduced peripheral IGFBP-3 levels. The operated children with initial OSAS experienced a highly significant reduction in their OAHI from 7.1 (95% CI: 5.1-9.1) to 0.37 (95% CI: 0.2-0.95). Weight-for-height, body mass index, body fat mass, and fat-free mass increased during the follow-up in the operated children with OSAS, whereas only fat-free mass and relative height increased in the PS children. Both the IGF-I and the IGFBP-3 concentrations increased significantly in the operated children, whereas no significant changes were seen in the PS children. These observations indicate that growth hormone secretion is impaired in children with OSAS and PS. Respiratory improvement after adenotonsillectomy in children with OSAS results in weight gain and restored growth hormone secretion.</description><subject>Adenoidectomy</subject><subject>Anthropometry</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Growth</subject><subject>Humans</subject><subject>Infant</subject><subject>Insulin-Like Growth Factor Binding Protein 3 - metabolism</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Male</subject><subject>Pediatrics</subject><subject>Sleep Apnea, Obstructive - complications</subject><subject>Sleep Apnea, Obstructive - physiopathology</subject><subject>Sleep Apnea, Obstructive - surgery</subject><subject>Snoring - complications</subject><subject>Snoring - physiopathology</subject><subject>Tonsillectomy</subject><subject>Weight Gain</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEtLxDAURoMoOj62LiW4cNeapMmkWY6DL1BcqLiSkKa3NmNfJq2D_96ODoy4ug_OPVw-hI4piang7LyDPMSUqJjHIMQWmox9GnEmxTaaEJLQiBMi9tB-CAtCCBeS7aI9ShWTkqUT9Hrt22VfYtPk-MK1toTaWVPhe-PfwQfcFnhNuAbPS1flHhr84sbFY9N617z9nD5kofeD7d0n4McKoMOzrgFziHYKUwU4WtcD9Hx1-TS_ie4erm_ns7vIJkL2UWJBpsQUTFrOlUmTjCjFM1sIoowxSk655ZYqM6UylywjjFpRWFbklCsuVXKAzn69nW8_Bgi9rl2wUFWmgXYIWlIhRwkbwdN_4KIdfDP-phlLEz5VP7b4F7K-DcFDoTvvauO_NCV6lbpepT4OSnM9pj4enKytQ1ZDvsHXMW-MpXsrl87DyuBM750Nf9qN8RtBPI5f</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>Nieminen, Peter</creator><creator>Lopponen, Tuija</creator><creator>Tolonen, Uolevi</creator><creator>Lanning, Peter</creator><creator>Knip, Mikael</creator><creator>Lopponen, Heikki</creator><general>Am Acad Pediatrics</general><general>American Academy of Pediatrics</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20020401</creationdate><title>Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea</title><author>Nieminen, Peter ; Lopponen, Tuija ; Tolonen, Uolevi ; Lanning, Peter ; Knip, Mikael ; Lopponen, Heikki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-3ce780af27c449a83b0994bcf509aaa9764c4c19a617d72b021c5fc2fd1494793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adenoidectomy</topic><topic>Anthropometry</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Growth</topic><topic>Humans</topic><topic>Infant</topic><topic>Insulin-Like Growth Factor Binding Protein 3 - metabolism</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Male</topic><topic>Pediatrics</topic><topic>Sleep Apnea, Obstructive - complications</topic><topic>Sleep Apnea, Obstructive - physiopathology</topic><topic>Sleep Apnea, Obstructive - surgery</topic><topic>Snoring - complications</topic><topic>Snoring - physiopathology</topic><topic>Tonsillectomy</topic><topic>Weight Gain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nieminen, Peter</creatorcontrib><creatorcontrib>Lopponen, Tuija</creatorcontrib><creatorcontrib>Tolonen, Uolevi</creatorcontrib><creatorcontrib>Lanning, Peter</creatorcontrib><creatorcontrib>Knip, Mikael</creatorcontrib><creatorcontrib>Lopponen, Heikki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nieminen, Peter</au><au>Lopponen, Tuija</au><au>Tolonen, Uolevi</au><au>Lanning, Peter</au><au>Knip, Mikael</au><au>Lopponen, Heikki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>2002-04-01</date><risdate>2002</risdate><volume>109</volume><issue>4</issue><spage>e55</spage><epage>e55</epage><pages>e55-e55</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>The pathophysiological mechanisms of growth impairment frequently associated with the obstructive sleep apnea syndrome (OSAS) in children are poorly defined. The main objective of this study was to evaluate whether nighttime upper airway obstruction attributable to adenotonsillar hypertrophy and subsequent surgical treatment affect the circulating concentrations of insulin-like growth factor-I (IGF-I) and IGF-binding protein 3 (IGFBP-3) along with other growth parameters in children. We initially studied 70 children (mean age: 5.8 years; range: 2.4-10.5 years) admitted to a university hospital because of clinical symptoms of OSAS. Their sleep was monitored with a 6-channel computerized polygraph. Data on anthropometry and circulating concentrations of IGF-I and IGFBP-3 were generated and compared with corresponding characteristics in control children (N = 35). Thirty children with an obstructive apnea-hypopnea index (OAHI) of 1 or more were categorized as children with OSAS (mean OAHI: 5.4 [95% confidence interval for mean (CI): 3.8-6.9]), whereas 40 children with an OAHI of &lt;1 were considered as primary snorers (PS) (mean OAHI 0.13 [95% CI: 0.05-0.21]). Nineteen children with OAHI &gt;2 underwent adenotonsillectomy attributable to OSAS and were reassessed 6 months later together with 34 nonoperated children with OAHI &lt;2. There were no initial differences in relative height and weight for height between the 3 groups of children. No differences were observed in peripheral IGF-I concentrations, but both OSAS and PS children had reduced peripheral IGFBP-3 levels. The operated children with initial OSAS experienced a highly significant reduction in their OAHI from 7.1 (95% CI: 5.1-9.1) to 0.37 (95% CI: 0.2-0.95). Weight-for-height, body mass index, body fat mass, and fat-free mass increased during the follow-up in the operated children with OSAS, whereas only fat-free mass and relative height increased in the PS children. Both the IGF-I and the IGFBP-3 concentrations increased significantly in the operated children, whereas no significant changes were seen in the PS children. These observations indicate that growth hormone secretion is impaired in children with OSAS and PS. Respiratory improvement after adenotonsillectomy in children with OSAS results in weight gain and restored growth hormone secretion.</abstract><cop>United States</cop><pub>Am Acad Pediatrics</pub><pmid>11927728</pmid><doi>10.1542/peds.109.4.e55</doi></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 2002-04, Vol.109 (4), p.e55-e55
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_miscellaneous_71577642
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adenoidectomy
Anthropometry
Child
Child, Preschool
Female
Follow-Up Studies
Growth
Humans
Infant
Insulin-Like Growth Factor Binding Protein 3 - metabolism
Insulin-Like Growth Factor I - metabolism
Male
Pediatrics
Sleep Apnea, Obstructive - complications
Sleep Apnea, Obstructive - physiopathology
Sleep Apnea, Obstructive - surgery
Snoring - complications
Snoring - physiopathology
Tonsillectomy
Weight Gain
title Growth and Biochemical Markers of Growth in Children With Snoring and Obstructive Sleep Apnea
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A05%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20and%20Biochemical%20Markers%20of%20Growth%20in%20Children%20With%20Snoring%20and%20Obstructive%20Sleep%20Apnea&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Nieminen,%20Peter&rft.date=2002-04-01&rft.volume=109&rft.issue=4&rft.spage=e55&rft.epage=e55&rft.pages=e55-e55&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.109.4.e55&rft_dat=%3Cproquest_cross%3E126443601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228346979&rft_id=info:pmid/11927728&rfr_iscdi=true